7,541.40

-38.67

-0.51%

51,983.98

+213.67

+0.41%

25,164.32

-272.68

-1.07%

2,805.88

-5.97

-0.21%

4.8940

-0.0350

-0.71%

21.15

+1.73

+8.91%

3,956.60

+57.70

+1.48%

76,816.55

-887.53

-1.14%

Crude Oil Dec 26

96.26

-7.86

-7.55%

US Private Equity

10,850.63

-82.20

-0.75%

LIVE It’s John Ternus’ first earnings call as Apple CEO. Listen in here.

NasdaqCM - Nasdaq Real Time Price USD

Co-Diagnostics, Inc. (CODX)

0.3533 -0.0134 (-3.65%)

At close: 4:00:01 PM EST

0.3700 +0.0167 (+4.73%)

After hours: 4:31:51 PM EST

Loading Chart for CODX

Chart Range Bar

Interval:

In partnership with ChartIQ

Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast

Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast

Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India

Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India

Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum

Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum

Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection

Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection

Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe

Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe

Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease

Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease

Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week

Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week

Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026

Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026

Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola

Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola

Co-Diagnostics to Hold Press Conference

Co-Diagnostics to Hold Press Conference

Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base

Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base

Mobilize your Website

View Site in Mobile | Classic

Share by: